Ethacrynic acid (MK-595) 1 is a new orally active saluretic agent structurally unrelated to organomercurial or benzothiadiazine diuretics (2) . Its biological properties in experimental animals were first studied by Baer, Russo, Michaelson, and Beyer (3, 4) , who reported it to be a natriuretic drug more potent than chlorothiazide and suggested that it might have a novel mode of action. Clinically, its potency seems to be comparable to parenterally administered organomercurials, and it has been effective in patients previously refractory to other diuretics (5, 6) . Because of the potential importance of this drug as an effective agent in the treatment of edema, the present study was undertaken to gain knowledge of the site or sites of action of the drug in the human kidney by determining its effects on urinary dilution and concentration.
Knowledge of the mechanisms of urinary concentration and dilution, recently reviewed by Gottschalk (7) and Ullrich, Kramer, and Boylan (8) , has provided a basis for studying the locus of action of diuretics in the kidney of intact subjects. In the normal kidney, after reabsorption of approximately two-thirds of filtered sodium and water in isotonic proportions in the proximal convoluted tubule, the remaining urine may be * Submitted for publication September 3, 1963 ; accepted October 8, 1963. Supported by U. S. Public Health Service grants HE 07284-02, HE 0034014, and 8MO1 FR 40-03 and the C. Mahlon Kline Fund for the development of the Department of Medicine.
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diluted or concentrated in the loop of Henle and distal nephron. In the ascending limb of Henle's loop, sodium is actively reabsorbed in excess of water, resulting in the production of a dilute urine in the tubular lumen before passage of the fluid from the ascending limb into the early distal tubule. Simultaneously, the solute reabsorbed in the loop is extruded into the renal medulla where the countercurrent multiplier system maintains a markedly hypertonic inner medulla. In the presence of antidiuretic hormone (ADH), the final urine is concentrated by the passive movement of solute free water from isotonic urine in the collecting duct into the hypertonic medulla. In the absence of ADH (water diuresis), the hypotonic urine entering the early distal tubule is diluted further by the reabsorption of sodium at water-impermeable sites. Thus urinary dilution or free water generation may occur at two sites in the nephron-the first site in the ascending limb of Henle's loop where the extracted solute is also involved in the mechanism of concentration of the final urine and the second site in the distal tubule [and possibly also the collecting duct (9, 10) ] where dilution occurs by processes not directly related to the countercurrent mechanism.
Based on these concepts, a diuretic acting solely in the proximal tubule would be expected to enhance free water clearance (CHo) during water diuresis because more sodium would be presented to both of the diluting sites for reabsorption, and also there would be relatively less ADH-independent back diffusion of water from the collecting duct at high rates of urine flow (11) . During hydropenia, a proximally acting drug would increase reabsorption of solute-free water by the collecting duct (TH,,o) because of the availability of more osmotically active solute for 201 transport into the medulla. Indeed, nonspecific osmotic or solute diuretics have been shown to increase CH2o (12) (13) (14) (15) and TCH2O (14, (16) (17) (18) during water diuresis and hydropenia, respectively. Drugs acting in the distal nephron would have more variable effects. For example, chlorothiazide decreases CH20 in hydrated dogs (14) and humans (19) , but does not decrease Tc112o during hydropenia (14, 19) . This suggests an action in the distal tubule at the second diluting site (14) . To date, no natriuretic agent has been shown to lower both CH20 during water diuresis and TCH20 during hydropenia, the requirements necessary to invoke a site of action in the loop of Henle. The results of the present study strongly suggest a site of action of ethacrynic acid in Henle's loop, since this drug lowers both CE20 and TCH20 over a wide range of solute excretion.
Methods
Twenty-seven acute studies were performed on eighteen healthy human volunteers and two patients with diabetes insipidus in the Clinical Research Center of the Hospital of the University of Pennsylvania. The effects of ethacrynic acid were observed both during water diuresis and during hydropenia.
Water diuresis|
Ten experiments were performed in seven normal volunteers and two patients with diabetes insipidus. The subjects, who maintained their usual dietary intake, omitted fluids after midnight and reported for study at 8:30 to 9:00 a.m. After standing to empty the bladder, the subject assumed the recumbent position for the remainder of the study except to stand to void. In the two female patients with diabetes insipidus, an indwelling catheter was inserted, and urine was collected by using suprapubic pressure and bladder washout with air. A priming dose of inulin was administered, and a sustaining infusion of inulin in physiological saline was maintained at a rate of 1 ml per minute throughout the experiment. After a 45-minute urine collection period, an oral load of tap water (20 ml per kg body weight) was ingested in 20 to 30 minutes. Urine was collected every 15 to 20 minutes. After each urine collection, water was administered by mouth equal in volume to the volume of the urine passed during the previous period plus water at a rate of 0.7 to 1.0 ml per minute to replace insensible loss. In the normal subjects, this procedure induced a state of sustained maximal water diuresis ("physiological diabetes insipidus"). When urine flow was stable, within 1 ml per minute, for at least three consecutive periods, 150 mg of ethacrynic acid was administered by mouth, and fluid replacement was continued after each period at a rate equal to that required just before ingestion of the drug. Blood specimens were drawn about every 60 to 90 minutes at the mid-point of a collection period. The study was considered valid only if venipuncture had no observable effect on the sustained water diuresis (i.e., on urine flow or urine osmolality). Glomerular filtration rate (GFR) was estimated by inulin clearance (Ci.) in one control experiment and in four of the five studies involving the administration of ethacrynic acid. In the remainder of experiments during water diuresis, endogenous creatinine clearance (CCr) was used to estimate GFR.
Two types of control experiments were performed. In two subj ects, a sustained water diuresis without any drug administration was continued for 3 hours to assess the adequacy of the hydrating procedure in maintaining a steady state. In three subjects, after institution and maintenance of the sustained water diuresis as described above, an iv infusion of 3.75% mannitol was begun at a rate of 20 ml per minute and maintained for 3 to 4 hours. These latter experiments were used to compare the effects of osmotic diuresis with those of ethacrynic acid on water diuresis.
Hydropenia
Seventeen experiments were performed in fourteen healthy male volunteers. The subjects were maintained on their usual diets. Food and fluids were omitted for 15 to t Clearance of endogenous creatinine. All other values for GFR represent inulin clearance.
by the method of Walser, Davidson, and Orloff (22) . COsm, CH20, and TCH2O were calculated by the following formulas: Cogm = UosmV/Posm, CH.o = V -Cosm during water diuresis, and TCH20 = Cosm-V during hydropenia, where Uosm = osmolality of urine (mOsm per kg), Posm = osmolality of serum (mOsm per kg), and V =urine flow (ml per minute).
Results

Studies in hydrated subjects
Control studies. Effects of osmotic diuresis superimposed on water diuresis. The first two protocols in Table I show one experiment in which maximal diuresis was sustained for 3 hours and one typical experiment in which mannitol diuresis was superimposed on sustained water diuresis. The first experiment illustrates the adequacy of the hydrating procedure in maintaining a steady state of hydration with regard to Uosm, V, and CH20 In the experiment with mannitol, as Cosm increased from 2.9 to 11.7 ml per minute, there was a progressive rise in CH20 from a mean control value of 9.6 ml per minute to 10.7 ml per minute. Qualitatively similar changes in CH2o were observed in the other two subjects during water diuresis and superimposed mannitol diuresis (Table II) . The greatest increment in CH20 occurred in subject EH in whom CH20 increased from 8.6 to 14.9 ml per minute, while Cosm increased from 3.5 to 13.9 ml per minute. These results agree with the data of other investigators who studied the effects of mannitol diuresis in hydrated subjects or animals (12) (13) (14) (15) .
Effects of ethacrynic acid in normal hydrated subjects and patients with diabetes insipidus. Figure 1 15 .2%o of the estimated filtered load of sodium. In contrast to the effects of mannitol diuresis, however, there was a distinct decrease in CH2o after ethacrynic acid. As illustrated in Table II , CHio decreased in all experiments in which ethacrynic acid diuresis was superimposed on water diuresis. CHO fell more than 4 ml per minute in four of the five experiments, the maximal fall in CH2O ranging from 2.0 to 6.1 ml per minute. Although CH2o approached its minimal value during the peak of saluresis, it continued to fall in three of the five subjects even as solute excretion was decreasing, so that the minimal value for CHO occurred during the descending limb of the saluresis at values of Cosm varying from 14.3 to 5.4 ml per minute.
In one normal subject (RR) and in one patient with diabetes insipidus (AB), the maximal Cosm and the minimal CH2O occurred simultaneously.
Although the major rise in solute excretion caused by ethacrynic acid consisted of a marked natriuresis and chloruresis, appreciable increases in the excretion of potassium, titratable acid, and ammonium also occurred. As seen in Table II Figure  3 showing the effects on V; Uosm/Posm; Cosm; TcH2o; sodium, chloride, and potassium excretion; and C1,,. Figure 4 . The relationships between TCH20 and Cosm in four experiments in which either 3% saline (two subjects) or hypertonic mannitol (two subjects) was administered after the onset of action of ethacrynic acid are illustrated in Figure 5 , A.
III, B. A typical study is illustrated in
As in the previous group of studies, in every subject TCH2o decreased below control values as COsm increased due to ethacrynic acid. After hypertonic mannitol was begun, TCHO0 rose slightly and transiently in one subject (AE) and then fell progressively to values less than 1 ml per minute as Cosm increased. In subject WR, whose study is illustrated in the lower chart in Figure 4 , despite the administration of mannitol, TCH20 progressively fell to zero. In both experiments with 3%O saline, TCHO increased slightly to 3.2 ml per minute at a Cosm of 34.7 ml per minute in subject EH, but did not rise above 1.5 ml per minute in the other subject (MA). Thus, compared to the control studies, ethacrynic acid blocked the rise in TCHo normally occurring with osmotic diuresis during hydropenia. These studies are summarized in Table III , D. In Figure 4 , the upper and middle charts illustrate two different experiments in the same subject. The upper chart shows a control study with 10%o mannitol in saline in subject RK in which TCHIG remained relatively constant between 6.6 and 7.1 ml per minute at values of Cosm varying from 10 to 41 ml per minute. In the experiment represented in the middle chart, after a mannitol diuresis was established and TCH2o had approached its maximal value at a Cosm of 15 ml per minute, ethacrynic acid was given. In 50 minutes TCH2O had decreased to 4.3 ml per minute at a Cosm of 30 ml per minute, and later when Cosm was 38 ml per minute, TCH2O reached 0.7 ml per minute. At comparable values of Cosm in the control experiment, TCHIO exceeded 6 ml per minute. There was also a difference between the curves representing the Uo.m/Posm ratios in the two experifments. These curves were almost identical until the effects of ethacrynic acid became manifest in the second study. After this, the Uo.m/Po.m ratio decreased rapidly towards 1.0 (i.e., the urine was virtually isotonic to blood). In the control mannitol diuresis, however, even at a CO.m of 41 ml per minute, the UO../Po.m ratio was 1.20. In the other three experiments utilizing the same protocol, the results were qualitatively the same (Table III, D) . Figure 5, solute excretion, the kidneys are unable to concentrate the urine.
Discussion From these studies, it is apparent that ethacrynic acid has a definite effect on the renal processes of dilution and concentration. During maximal water diuresis, the increase in Co.m (predominantly due to a sodium chloride diuresis) was proportionately greater than the rise in urine flow. Hence, CH2o was reduced in association with a rise in Uosm. This effect of the drug could be due to a locus of action in either of the two diluting sites-the ascending limb of Henle's loop or the distal tubule. An action solely in the distal tubule affecting dilution would be expected to increase solute excretion without appreciably increasing urine flow (14) . Consequently, if ethacrynic acid were to act in the distal tubule, another simultaneous effect would have to be postulated at a site where solute is reabsorbed isosmotically, such as the proximal tubule, to account for the significant rise in urine volume after the drug. As pointed out by several investigators (13, 14, 19) , action of a drug solely in the proximal convoluted tubule could not explain a decrease in CH2O. Like the control studies with mannitol, a proximally acting drug would be expected to increase CI20 in contrast to our observations with ethacrynic acid. On the other hand, an effect in the ascending limb of Henle's loop could account for the decrease in CH,0 and, in large part, the rise in both solute excretion and urine volume. According to micropuncture studies in the rat, approximately 10 to 15% of filtered water is reabsorbed in the loop of Henle (23) . Solute (i.e., sodium chloride) reabsorption in the loop is greater than water reabsorption, corresponding to approximately 14 to 21%o of filtered sodium.2 A drug that would completely inhibit sodium reabsorption in the ascending limb during maximal water diuresis would be expected to cause 1) predominantly a sodium chloride diuresis, 2) a decrease in CHI20 but not to 0 since a more distal diluting site would still be intact, and 3) a rise both in solute excretion and urine volume in relatively hypertonic proportions. Ethacrynic acid appears to meet these requirements qualitatively. During water diuresis, maximal sodium-excretion due to etha-crynic acid was 13 to 15% of the estimated filtered load. Obviously, quantitative comparison of our data with rat micropuncture data is not possible. The rise in potassium, titratable acid, and ammonium excretion following ethacrynic acid suggests that sodium reabsorption occurred distal to the loop of Henle (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Hence, a portion of sodium rejected proximal to the distal tubule and collecting duct would not have been excreted.
Detailed studies on hydropenic subjects were performed to localize further the site of action of ethacrynic acid. If the drug impaired dilution by an action distal to the loop of Henle, then TCHO might be expected to increase or remain unchanged (14, 18) . On the other hand, inhibition of sodium reabsorption in the ascending limb would disrupt the countercurrent multiplier system and prevent the hypertonic accumulation of medullary solute. Therefore, TCHO would decrease, since the osmotic gradient between the medulla and collecting duct would be markedly reduced or obliterated. Such indeed was the case after ethacrynic acid. When the drug was administered at either low or high initial rates of solute excretion, TCu2o consistently decreased regardless of its preceeding value. In several subjects TCH2O fell to less than 1 ml per minute and in one subject reached 0.
These results were in striking contrast to the control studies of nonspecific solute diuresis with hypertonic mannitol or saline. In the latter experiments, increasing quantities of sodium entering the loop from the proximal tubule were available for reabsorption in the ascending limb. Thus, more osmotically active solute accumulated in the hypertonic medulla to produce greater net movement of water into the medulla from the large volume of isotonic collecting duct urine. Similar to observations by other investigators (14, (16) (17) (18) (27, 28) .
It is theoretically possible that a locus of action of the drug on solute transport in the collecting duct could have contributed to some of its effects on dilution and concentration. Klumper, Ullrich, and Hilger (29) have demonstrated in the hamster that sodium is reabsorbed from the collecting duct urine. Studies of Jaenike and Berliner suggest that chloride is also removed (30) . Evidence is lacking that the salt transported out of the collecting duct contributes to the countercurrent system. Micropuncture studies in rodents have suggested that some degree of urinary dilution may be achieved in the collecting duct (9, 10). These movements of solute, however, although probably important in the regulation of sodium excretion, apparently make a relatively minor contribution to the over-all processes of dilution and concentration. Compared to the magnitude of the changes observed in our studies, it is most unlikely that the sole or most important action of ethacrynic acid is in the collecting duct, if it acts there at all.
Thus, the evidence strongly suggests that a major site of action of ethacrynic acid is in the loop of Henle. Inhibition of sodium chloride reabsorption in the ascending limb impairs a major component of the diluting mechanism and, by 213 blocking medullary solute accumulation, disrupts the concentrating mechanism. Our data do not eliminate the possibility of an additional action of the drug in the proximal convoluted tubule. Although the increment of saluresis in our studies approached the magnitude of solute estimated to be reabsorbed in the loop, it is possible that under other experimental or clinical conditions a greater solute diuresis might be demonstrable. The final solution to this problem will have to come through micropuncture studies in the dog or monkey, since the drug is ineffective in the rodent (3, 4) .
While this study was in progress, a preliminary report on the use of ethacrynic acid in thirteen edematous patients was presented by Nash and associates (31 (19) . In contrast, however, chlorothiazide had no effect on TCH2O in one hydropenic human subject (19) and produced a greater increase in TCH2O than did mannitol diuresis in dogs at high rates of solute excretion (14) . Because of these observations, Earley, Kahn, and Orloff (14) postulated an action of chlorothiazide at the diluting site in the distal nephron distal to the loop of Henle. Interpretation of the data in the literature on studies with organomercurial diuretics on renal dilution and concentration with respect to site of action is more difficult. In some studies, impairment in the concentrating mechanism has been reported (34, 35) , and in some, enhancement of CH2o with meralluride has been observed (19, 36 
Summary
The effects of ethacrynic acid, a new orally active diuretic agent, on the renal mechanisms of dilution and concentration were studied. Twentyseven acute experiments were performed on eighteen normal human subjects and two patients with diabetes insipidus. The experimental conditions included water diuresis and hydropenia with and without superimposed osmotic diuresis.
Ethacrynic acid caused primarily a natriuresis and chloruresis and had a distinct effect on both free water clearance (CH20) during maximal water diuresis and tubular reabsorption of solutefree water (TCH2o) during hydropenia. In maximally hydrated normal subjects and in patients with diabetes insipidus, CH20 was significantly decreased as osmolar clearance increased, in contrast to mannitol diuresis. The drug also caused a moderate reduction in glomerular filtration rate and an increase in the excretion of potassium and hydrogen ions.
During hydropenia, TCH20 was markedly decreased at both low and high rates of solute excretion. Hypertonic mannitol or saline diuresis, which in themselves increased TCH2O, when superimposed on a diuresis due to ethacrynic acid, could not raise TCH20 to normal levels. Characteristically, during the peak of diuresis caused by the drug, a virtually isotonic urine was excreted at various levels of solute clearance, and this effect persisted even after the peak of saluresis.
These results differentiate ethacrynic acid qualitatively from other diuretic agents and suggest that an important locus of action is in the ascending limb of the loop of Henle where sodium chloride is reabsorbed in excess of water. This hy-pothesis would explain the effects of ethacrynic acid on both the renal diluting and concentrating mechanisms and also could account in large part for the type and magnitude of the solute diuresis following administration of the drug.
